Indicators

Markets:

News

Latest News about REGN

Recent news which mentions REGN

...

19 20 21 22 23 24 25 26 27

...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $3,900 Today

September 02, 2022

What Are Whales Doing With Regeneron Pharmaceuticals

September 01, 2022

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know

August 31, 2022

Alnylam Posts Mid-Stage Study Data From Regeneron-Partnered Kidney Disease Drug

August 29, 2022

5 Top Stocks Cathie Wood Is Selling This Week

August 26, 2022

Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

August 24, 2022

Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments

August 19, 2022

Amgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug

August 16, 2022

2 Top Biotech Stocks to Buy Right Now

August 12, 2022

3 Best Funds for Aggressive Investors

August 11, 2022

Obsessing over CPI? You could be missing bargain stocks that can build long-term returns, say these fund managers

August 10, 2022

Kodiak's Eye Disease Candidate At Par With Regeneron's Eylea In Visual Acuity Gains

August 08, 2022

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

August 06, 2022

7 Cheap Biotech Stocks to Buy Now

August 03, 2022

$100 Invested In This Stock 15 Years Ago Would Be Worth $3,300 Today

August 03, 2022

Regeneron's Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity

August 03, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

Biotech Investors: August's Key PDUFA Catalysts You Must Know

July 31, 2022

2 Cheap Dividend Stocks Yielding More Than 4%

July 31, 2022

How This Multibillion-Dollar Company Is Shaking Off the Competition

July 30, 2022

7 Cathie Wood Stocks Trading at a Discount Right Now

July 26, 2022

Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product

July 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022

July 25, 2022

Meta Platforms To $250? Plus This Analyst Lowers Price Target On Microsoft

July 25, 2022

2 Pharma Giants With Momentum That Could Carry Through 2030

July 22, 2022

Where Regeneron Pharmaceuticals Stands With Analysts

July 20, 2022

3 High-Margin Businesses That Can Absorb Inflation

July 20, 2022

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

July 18, 2022

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures

July 14, 2022

Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years

July 14, 2022

...

19 20 21 22 23 24 25 26 27

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.